This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Pittsburgh, University of Virginia Patent Foundation, Bluefin Biomedicine, Inc.. Active years: 1998-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 1,960 
2 out of 1,044 
1 out of 17 
Years Active: 1998-2022
Title: The Innovative Contributions of Olivera J Finn
Introduction
Olivera J Finn is a prominent inventor based in Pittsburgh, PA, known for her significant contributions to the field of cancer research. With a total of nine patents to her name, she has made remarkable strides in developing therapeutic and diagnostic tools aimed at combating cancer. Her work focuses on innovative approaches to target tumor-associated antigens, which are crucial in the fight against cancer.
Latest Patents
Among her latest patents is the invention titled "Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen." This invention provides an isolated nucleic acid encoding a receptor that binds to the MUC1 tumor antigen independently of a major histocompatibility complex (MHC). The invention also outlines a method for activating a signaling pathway and/or killing a cancer cell using a receptor similar to a T cell receptor. Another notable patent is "Anti-mucin 1 binding agents and uses thereof," which discloses anti-MUC1 binding agents, including antibodies and chimeric antigen receptors, along with methods for treatment, prophylaxis, detection, and diagnosis.
Career Highlights
Olivera J Finn has had a distinguished career, working at esteemed institutions such as the University of Pittsburgh and the University of Virginia. Her research has not only advanced scientific understanding but has also paved the way for new therapeutic strategies in oncology.
Collaborations
Throughout her career, Olivera has collaborated with notable colleagues, including Nehad M Alajez and Jan Schmielau. These collaborations have further enriched her research and contributed to the development of innovative cancer treatments.
Conclusion
Olivera J Finn's contributions to cancer research through her patents and collaborations highlight her as a leading figure in the field. Her innovative work continues to inspire advancements in therapeutic and diagnostic methods for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile